ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 230 filers reported holding ICU MED INC in Q1 2023. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $297,525 | -33.2% | 2,500 | 0.0% | 0.05% | -28.4% |
| Q2 2023 | $445,475 | +8.0% | 2,500 | 0.0% | 0.07% | -8.2% |
| Q1 2023 | $412,400 | +4.7% | 2,500 | 0.0% | 0.07% | -5.2% |
| Q4 2022 | $393,700 | +4.4% | 2,500 | 0.0% | 0.08% | 0.0% |
| Q3 2022 | $377,000 | -8.3% | 2,500 | 0.0% | 0.08% | -7.2% |
| Q2 2022 | $411,000 | -26.2% | 2,500 | 0.0% | 0.08% | +16.9% |
| Q1 2022 | $557,000 | -6.1% | 2,500 | 0.0% | 0.07% | +36.5% |
| Q4 2021 | $593,000 | +15.4% | 2,500 | 0.0% | 0.05% | +23.8% |
| Q2 2021 | $514,000 | 0.0% | 2,500 | 0.0% | 0.04% | -12.5% |
| Q1 2021 | $514,000 | -14.5% | 2,500 | -10.7% | 0.05% | -7.7% |
| Q4 2020 | $601,000 | +17.6% | 2,800 | 0.0% | 0.05% | +6.1% |
| Q3 2020 | $511,000 | -1.0% | 2,800 | 0.0% | 0.05% | -5.8% |
| Q2 2020 | $516,000 | -8.7% | 2,800 | 0.0% | 0.05% | -40.9% |
| Q1 2020 | $565,000 | -3.3% | 2,800 | -10.3% | 0.09% | -3.3% |
| Q4 2019 | $584,000 | +17.3% | 3,120 | 0.0% | 0.09% | +9.6% |
| Q3 2019 | $498,000 | -36.6% | 3,120 | 0.0% | 0.08% | -29.1% |
| Q2 2019 | $786,000 | +5.2% | 3,120 | 0.0% | 0.12% | -6.4% |
| Q1 2019 | $747,000 | -6.2% | 3,120 | -10.0% | 0.12% | -21.4% |
| Q4 2018 | $796,000 | -18.7% | 3,465 | 0.0% | 0.16% | +4.6% |
| Q3 2018 | $979,000 | -3.7% | 3,465 | 0.0% | 0.15% | -7.9% |
| Q2 2018 | $1,017,000 | +16.2% | 3,465 | 0.0% | 0.16% | +2.5% |
| Q1 2018 | $875,000 | +5.2% | 3,465 | -10.0% | 0.16% | -12.0% |
| Q4 2017 | $832,000 | +4.7% | 3,850 | -9.9% | 0.18% | -2.7% |
| Q3 2017 | $795,000 | +7.9% | 4,275 | 0.0% | 0.19% | -3.1% |
| Q2 2017 | $737,000 | +13.0% | 4,275 | 0.0% | 0.19% | +2.1% |
| Q1 2017 | $652,000 | +3.7% | 4,275 | 0.0% | 0.19% | -9.1% |
| Q4 2016 | $629,000 | +16.5% | 4,275 | 0.0% | 0.21% | +14.8% |
| Q3 2016 | $540,000 | +12.0% | 4,275 | 0.0% | 0.18% | +4.0% |
| Q2 2016 | $482,000 | +8.3% | 4,275 | 0.0% | 0.18% | +43.4% |
| Q1 2016 | $445,000 | -7.7% | 4,275 | 0.0% | 0.12% | -22.8% |
| Q4 2015 | $482,000 | +3.0% | 4,275 | 0.0% | 0.16% | -7.1% |
| Q3 2015 | $468,000 | -35.4% | 4,275 | -43.6% | 0.17% | -33.9% |
| Q2 2015 | $725,000 | -47.0% | 7,575 | -48.4% | 0.26% | -49.0% |
| Q1 2015 | $1,367,000 | +6.5% | 14,675 | -6.4% | 0.50% | +2.4% |
| Q4 2014 | $1,284,000 | +10.7% | 15,675 | -13.3% | 0.49% | +10.8% |
| Q3 2014 | $1,160,000 | -10.8% | 18,075 | -15.4% | 0.44% | -12.6% |
| Q2 2014 | $1,300,000 | +1.6% | 21,375 | 0.0% | 0.51% | -3.1% |
| Q1 2014 | $1,280,000 | -6.0% | 21,375 | 0.0% | 0.52% | -3.9% |
| Q4 2013 | $1,362,000 | -6.2% | 21,375 | 0.0% | 0.54% | -17.0% |
| Q3 2013 | $1,452,000 | -25.6% | 21,375 | -21.1% | 0.66% | -34.9% |
| Q2 2013 | $1,951,000 | – | 27,075 | – | 1.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVR Research LP | 22,000 | $4,719,000 | 3.86% |
| NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
| Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
| Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
| PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
| KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
| PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
| Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
| Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |